Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Immunomedics ADCs bought for 21B$

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 04, 2023 8:48am

338 Views

Post# 35525495

RE:RE:Immunomedics ADCs bought for 21B$

Legit62 ... I post these types of articles to show some specific issues to show the potential, to show how little toxicity we have comoared to them, how more potent our technology can be, etc ...

We will first start with a jv with the NMIBC indication and then, on Ph. 1b data on NSCLC and/or GBM, if data looks once again superior to SOC and competition, we get bought.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market